Search
for
Did you mean Receptor Tyrosine Kinase Signaling?
Sort by
Research 30 of 1000+
- Receptor tyrosine kinase Kit action in skin melanocytes: is it exclusively cell autonomous?
- Tyrosine kinase inhibition and grey hair
- Identification of key genes and signaling pathways related to Hetian sheep wool density by RNA-seq technology
- Hair graying and loss induced by imatinib mesylate
- c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Gab1 and Mapk Signaling Are Essential in the Hair Cycle and Hair Follicle Stem Cell Quiescence
- Botryococcus terribilis Ethanol Extract Exerts Anti-inflammatory Effects on Murine RAW264 Cells
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Immunohistochemical study assessing stem cell factor receptor C-kit in patients with alopecia
- The PDGF/PDGFR pathway as a drug target
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Rapid hair depigmentation in patient treated with pazopanib